Early evaluation and value-based pricing of regenerative medicine technologies.

Abstract:

:Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful marketing by establishing the value of a product from a healthcare system perspective. This article reports results from a research project on early health economic evaluation in collaboration with developers, clinicians and manufacturers. We present an approach to determine an early value-based price for a new treatment of cartilage defects of the knee from the area of regenerative medicine. Examples of using evaluation results for the purpose of business planning, market entry, preparing the coverage decision and managed entry are discussed.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Koerber F,Rolauffs B,Rogowski W

doi

10.2217/rme.13.69

subject

Has Abstract

pub_date

2013-11-01 00:00:00

pages

747-58

issue

6

eissn

1746-0751

issn

1746-076X

journal_volume

8

pub_type

杂志文章
  • The role of policies and networks in development of cord blood usage in China.

    abstract::Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This articl...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0050

    authors: Chang HC

    更新日期:2017-09-01 00:00:00

  • Short-term outcomes after pure bone marrow aspirate injection for severe knee osteoarthritis: a case series.

    abstract::Background: Bone marrow aspiration (BMA) is among a group of autologous cell-based therapies currently being explored to treat osteoarthritis (OA). Materials & methods: This retrospective case study observed ten patients (13 knees) with severe knee OA who failed extensive conservative treatment and were treated with B...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0113

    authors: Colberg RE,Jurado Vélez JA,Walsh KP,Fleisig G

    更新日期:2020-07-01 00:00:00

  • Optimizing the safety of intradiscal platelet-rich plasma: an in vitro study with Cutibacterium acnes.

    abstract::Aim: The most common risk associated with intradiscal injection of platelet-rich plasma (PRP) is discitis with Cutibacterium acnes. It is hypothesized that antimicrobial activity of PRP can be enhanced through inclusion of leukocytes or antibiotics in the injectate. Materials & methods: Multiple PRP preparations of va...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0098

    authors: Prysak MH,Lutz CG,Zukofsky TA,Katz JM,Everts PA,Lutz GE

    更新日期:2019-10-01 00:00:00

  • Leukocyte-rich platelet-rich plasma application in post-traumatic osteoarthritis with popliteal cyst: a case report.

    abstract::Aim: To describe the successful treatment of a Baker's cyst in the setting of post-traumatic osteoarthritis using ultrasound-guided injection of platelet-rich plasma. Setting: Outpatient sports clinic. Patient: 29-year old male basketball player. Case description: The patient presented with 2-months history of right k...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0021

    authors: Song B,Yeh PC,Jayaram P

    更新日期:2020-06-01 00:00:00

  • Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

    abstract::Dimethyl sulfoxide (DMSO) is the cryoprotectant of choice for most animal cell systems since the early history of cryopreservation. It has been used for decades in many thousands of cell transplants. These treatments would not have taken place without suitable sources of DMSO that enabled stable and safe storage of bo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0145

    authors: Awan M,Buriak I,Fleck R,Fuller B,Goltsev A,Kerby J,Lowdell M,Mericka P,Petrenko A,Petrenko Y,Rogulska O,Stolzing A,Stacey GN

    更新日期:2020-03-01 00:00:00

  • Repurposing nano-enabled polymeric scaffolds for tumor-wound management and 3D tumor engineering.

    abstract::The main challenges of cancer drugs are toxicity, effect on wound healing/patient outcome and in vivo instability. Polymeric scaffolds have been used separately for tissue regeneration in wound healing and as anticancer drug releasing devices. Bringing these two together in bifunctional scaffolds can provide a tool fo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0072

    authors: Goonoo N,Boodhun A,Ziman M,Gray E,Bhaw-Luximon A

    更新日期:2020-10-01 00:00:00

  • Interview: stemming vision loss with stem cells: seeing is believing.

    abstract::Professor Coffey joined the faculty at the University of Oxford in 1987 on completing his doctoral work. In 1989, he was awarded a personal Royal Society Research Fellowship, at the same time moving to the University of Sheffield to establish a new laboratory for retinal transplantation. After 14 years at the Universi...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.33

    authors: Coffey P

    更新日期:2009-07-01 00:00:00

  • Diabetes mellitus: an opportunity for therapy with stem cells?

    abstract::In both Type 1 and 2 diabetes, insufficient numbers of insulin-producing beta-cells are a major cause of defective control of blood glucose and its complications. Restoration of damaged beta-cells by endocrine pancreas regeneration would be an ideal therapeutic option. The possibility of generating insulin-secreting c...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.3.3.377

    authors: Sordi V,Bertuzzi F,Piemonti L

    更新日期:2008-05-01 00:00:00

  • Global update: Germany.

    abstract::Researchers are working on key issues in regenerative medicine in many of the over 280 academic institutions in Germany. Moreover, nonuniversity research institutions such as Helmholtz-, Max-Planck-, Fraunhofer- and Leibniz-Centers provide important contributions to the field of regenerative medicine in Germany. Resea...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.64

    authors: Lauter FR,Wirsching S

    更新日期:2011-11-01 00:00:00

  • Culture conditions for primary human limbal epithelial cells.

    abstract::The cornea at the front of the eye is covered by an epithelium. This epithelium is maintained by stem cells located at the periphery of the cornea, in a region known as the limbus. Because this region harbors the stem cells for the corneal epithelium, the so-called limbal stem cells, its culture provides considerable ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.7

    authors: Osei-Bempong C,Henein C,Ahmad S

    更新日期:2009-05-01 00:00:00

  • Functional motor recovery after peripheral nerve repair with an aligned nanofiber tubular conduit in a rat model.

    abstract:AIM:Current synthetic tubular conduits are inferior to nerve autograft for the repair of segmental peripheral nerve injuries. We examined motor outcomes with the use of longitudinally aligned poly (L-lactide-co-caprolactone) nanofiber conduits for repair of nerve gap injury in a rat model. METHODS:Ten-millimeter segme...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.87

    authors: Jin J,Park M,Rengarajan A,Zhang Q,Limburg S,Joshi SK,Patel S,Kim HT,Kuo AC

    更新日期:2012-11-01 00:00:00

  • Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.

    abstract::In the past decade, stem cell therapy has been increasingly employed for the treatment of various diseases. Subsequently, there has been a great interest in the manufacture of stem cells under good manufacturing practice, which is required by law for their use in humans. The cells for sight Stem Cell Therapy Research ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2015-0020

    authors: Sheth-Shah R,Vernon AJ,Seetharaman S,Neale MH,Daniels JT

    更新日期:2016-04-01 00:00:00

  • Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

    abstract::Parkinson's disease and Alzheimer's disease are the most common neurodegenerative diseases in the elderly population. Given that age is the most important risk factor in these diseases, the number of patients is expected to rise dramatically in the coming years. Therefore, an effective therapy for these diseases is hi...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.2.4.425

    authors: Korecka JA,Verhaagen J,Hol EM

    更新日期:2007-07-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00

  • Tendon and ligament engineering: from cell biology to in vivo application.

    abstract::Tendons and ligaments are related connective tissues that join muscle to bone and bone to bone, respectively. Tendon and ligament injuries are widely distributed clinical problems in society and while healing of such disorders can occur, the original biological properties of the tissue do not return to normal. In this...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.4.563

    authors: Hoffmann A,Gross G

    更新日期:2006-07-01 00:00:00

  • The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics.

    abstract:AIM:This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the UK. MATERIALS & METHODS:Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-stru...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0041

    authors: Mahalatchimy A,Faulkner A

    更新日期:2017-09-01 00:00:00

  • A panel of tests to standardize the characterization of human embryonic stem cells.

    abstract::Human embryonic stem cells offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Characterizing these cells provides important information about their current state and affords relevant details for subsequent downstream manipulation. Prior to considering therapeutic appli...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.2.179

    authors: Pal R,Mandal A,Rao HS,Rao MS,Khanna A

    更新日期:2007-03-01 00:00:00

  • Enhancing medial layer recellularization of tissue-engineered blood vessels using radial microchannels.

    abstract::Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized arterial scaffolds is limited by dense concentric tunica media layers which impede cells migrating radially between the layers. We aimed to develop and validate a new microneedle device to modify decellularized carotid arteries wit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0011

    authors: Eufrásio-da-Silva T,Ruiz-Hernandez E,O'Dwyer J,Picazo-Frutos D,Duffy GP,Murphy BP

    更新日期:2019-11-01 00:00:00

  • Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

    abstract::Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicate...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.5.771

    authors: Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

    更新日期:2007-09-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • Cell therapy for spinal cord injury informed by electromagnetic waves.

    abstract::Spinal cord injury devastates the CNS, besetting patients with symptoms including but not limited to: paralysis, autonomic nervous dysfunction, pain disorders and depression. Despite the identification of several molecular and genetic factors, a reliable regenerative therapy has yet to be produced for this terminal di...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0019

    authors: Finnegan J,Ye H

    更新日期:2016-10-01 00:00:00

  • Research progress and prospects of tissue engineering scaffolds for spinal cord injury repair and protection.

    abstract::Spinal cord injury (SCI) is one of the leading causes of global disability. However, there are currently no effective clinical treatments for SCI. Repair of SCI is essential but poses great challenges. As a comprehensive treatment program combining biological scaffolds, seed cells and drugs or biological factors, tiss...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0156

    authors: Ma Z,Lu Y,Yang Y,Wang J,Kang X

    更新日期:2019-09-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • World Stem Cell Summit 2014. 3-5 December 2014, San Antonio, TX, USA.

    abstract::Among the many international conferences in the field of stem cells and regenerative medicine, WSCS is distinct in focusing its efforts to serve as the meeting point by multisector communities of research, clinics, industry, regulation, policy making and ethics. All are aiming at advancing stem cell innovation and new...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.15.4

    authors: Hasegawa K,Asada T,Sengoku S,Nakatsuji N

    更新日期:2015-05-01 00:00:00

  • Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia.

    abstract::Many of the current drug therapies for androgenetic alopecia were discovered serendipitously, with hair growth observed as an off-target effect when drugs were used to treat a different disorder. Subsequently, several studies using cultured cells have enabled identification of hair growth modulators with similar prope...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.87

    authors: Higgins CA,Christiano AM

    更新日期:2014-01-01 00:00:00

  • Methods and practices to diversify cell-based products.

    abstract::Medicinal signaling cell (MSC)-based products represent emerging treatments in various therapeutic areas including cardiometabolic, inflammation, autoimmunity, orthopedics, wound healing and oncology. Exploring innovation beyond minimally manipulated plastic-adherent ex vivo expanded allogeneic MSCs enables product de...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0093

    authors: Vertès AA

    更新日期:2017-12-01 00:00:00

  • Cell-based therapy approaches: the hope for incurable diseases.

    abstract::Cell therapies aim to repair the mechanisms underlying disease initiation and progression, achieved through trophic effect or by cell replacement. Multiple cell types can be utilized in such therapies, including stem, progenitor or primary cells. This review covers the current state of cell therapies designed for the ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.14.35

    authors: Buzhor E,Leshansky L,Blumenthal J,Barash H,Warshawsky D,Mazor Y,Shtrichman R

    更新日期:2014-01-01 00:00:00

  • Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis.

    abstract:AIM:In this study, we have evaluated the therapeutic efficacy of mouse multipotent adult progenitor cells (mMAPCs) in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, and compared it with mouse mesenchymal stem cells (mMSCs). MATERIALS & METHODS:We administered PKH26-labeled mMAP...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0109

    authors: Singh SP,Jadhav SH,Chaturvedi CP,Nityanand S

    更新日期:2017-04-01 00:00:00

  • Endotoxin-induced silencing of mesoderm induction and functional differentiation: role of HMGB1 in pluripotency and infection.

    abstract:OBJECTIVES:Mechanisms underpinning Gram-negative bacterial vaginosis-induced birth anomalies are obscure. Ethical issues limit such studies on peri-implantation-stage human embryos. Here we have used embryoid bodies (EBs) as an in vitro model to examine the effect of Gram-negative bacterial endotoxins/lipopolysaccharid...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.1.23

    authors: Sivasubramaniyan K,Atluri RR,Sarda K,Arvind M,Balaji V,Deb KD

    更新日期:2008-01-01 00:00:00

  • Autologous cell therapies: the importance of regulatory oversight.

    abstract::Promising new medical technologies and approaches to treatment offer the potential to substantially improve the lives of patients who need help, and in some cases transform the way medicine is practiced. In recent years, the biotechnology industry has generated many examples of new approaches that are having a profoun...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.90

    authors: Werner M,Mayleben T,Van Bokkelen G

    更新日期:2012-11-01 00:00:00